MTNB icon

Matinas BioPharma
MTNB

Overview Fund Activity

54 hedge funds and large institutions have $41.1M invested in Matinas BioPharma in 2019 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 5 closing their positions.

Holders
54
Holders Change
+19
Holders Change %
+54.29%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
10
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VC
1
Vivo Capital
California
$7.43M
2
BC
2
Boxer Capital
California
$11.1M
3
BC
3
Broadfin Capital
New York
$2.97M
4
SCM
4
Stonepine Capital Management
Oregon
$2.19M
5
Victory Capital Management
5
Victory Capital Management
Texas
$1.87M

Top Sellers

1
IA
1
IFP Advisors
Florida
$0
2
AGM
2
Alpine Global Management
New York
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
RJFSA
4
Raymond James Financial Services Advisors
Florida
$842K
5
Squarepoint
5
Squarepoint
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CAL
51
Capital Analysts LLC
Pennsylvania
$1K – – –
APA
52
American Portfolios Advisors
New York
$545 +$545 +10 New
BNP Paribas Financial Markets
53
BNP Paribas Financial Markets
France
$27 -$2.57K -95 -99%
IA
54
IFP Advisors
Florida
– -$1.08M -35,500 Closed
AGM
55
Alpine Global Management
New York
– -$245K -8,250 Closed
Citadel Advisors
56
Citadel Advisors
Florida
– -$61K -2,072 Closed
Squarepoint
57
Squarepoint
New York
– -$21K -710 Closed
Invesco
58
Invesco
Georgia
– -$15K -512 Closed
1 2
3